Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NanoViricides, Inc. (NNVC)

NYSE American - Nasdaq Real Time Price. Currency in USD
1.2799+0.0099 (+0.78%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.2700
Open1.2850
Bid1.2700 x 1800
Ask1.2800 x 900
Day's Range1.2700 - 1.2900
52 Week Range1.0400 - 2.0000
Volume16,157
Avg. Volume106,054
Market Cap14.973M
Beta (5Y Monthly)1.17
PE Ratio (TTM)N/A
EPS (TTM)-0.5700
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NNVC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NanoViricides, Inc.
    Analyst Report: Bristol-Myers Squibb Co.Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and cardiovascular conditions. The company completed its merger with Celgene in November 2019. BMY shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement